SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-11-000361
Filing Date
2011-11-03
Accepted
2011-11-03 17:28:13
Documents
3
Period of Report
2011-10-28
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1100220_8k-biozone.htm 8-K 34629
2 FORM OF NOTE EXTENSION AGREEMENT q1100220_ex10-1.htm EX-10.1 56653
3 GRAPHIC g10.gif GRAPHIC 11888
  Complete submission text file 0001521536-11-000361.txt   109312
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 111178677
SIC: 2834 Pharmaceutical Preparations